Nasdaq
AxoGen to Host Second Annual Analyst and Investor Day on November 20, 2017
07-11-2017
ALACHUA, Fla., Nov. 07, 2017 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for the repair of peripheral nerve damage, today announced that it will host its Second Annual Analyst and Investor Day on Monday, November 20, 2017 in New York City from 11:30 a.m. – 3:30 p.m. ET. AxoGen executives and surgeon thought leaders will discuss the company’s comprehensive platform for peripheral nerve repair and the emerging nerve repair market.
Latest Health & Supplement Reviews
- YuSleep Reviews (EXPOSED) Doctor Explains Deep Sleep Benefits, Hidden Risks & Real Consumers Results In 2026
- Neuro Energizer Reviews and Complaints 2026: How This Neuro-Sonic Breakthrough Is Reshaping Cognitive Therapy, Memory & Daily Focus
- Gluco6 Reviews and Complaints (March 2026) Real User Data on Natural Blood Sugar Balance and Glucose Stability